PureTech Health - Public Comps and Valuation Multiples

PureTech Health Overview

About PureTech Health

PureTech Health PLC is a biopharma company developing medicines to modulate the adaptive human system. It is a cross-disciplinary healthcare company developing products that could improve the lives of patients. The company is focused on developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic, and immunological conditions, intractable cancers, lymphatic & gastrointestinal diseases, and neurological & neuropsychological disorders, among others. It operates in the following segments: Wholly-Owned Programs, Controlled Founded Entities, and Parent Companies & Others. The company has a robust pipeline of advanced programs that are post-human proof of concept and focused on some of society's healthcare needs.

Founded

2015

HQ

Employees

Website

puretechhealth.com

Sectors

Drug Development & Therapeutics
Biopharmaceuticals
BioTech

Financials

LTM Revenue n/a

LTM EBITDA -$100M

EV

-$80.3M

Valuation Multiples

Multiples.vc

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

PureTech Health Financials

PureTech Health has a last 12-month revenue of n/a and a last 12-month EBITDA of -$100M.

In the most recent fiscal year, PureTech Health achieved revenue of $1.0M and an EBITDA of -$22.8M.

PureTech Health expects next 12-month revenue of XXX and NTM EBITDA of XXX

See PureTech Health valuation multiples based on analyst estimates

PureTech Health P&L

	FY 2023	FY 2024	FY 2025	LTM	NTM
Revenue	$1.0M	n/a	XXX	XXX	XXX
Gross Profit	n/a	n/a	XXX	XXX	XXX
Gross Margin	NaN%	NaN%	XXX	XXX	XXX
EBITDA	-$22.8M	-$126M	XXX	XXX	XXX
EBITDA Margin	-2357%	NaN%	XXX	XXX	XXX
Net Profit	-$78.0M	-$64.8M	XXX	XXX	XXX
Net Margin	-8074%	NaN%	XXX	XXX	XXX
Net Debt	n/a	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

PureTech Health Stock Performance

As of April 24, 2025, PureTech Health's stock price is GBP 1 (or $2).

PureTech Health has current market cap of GBP 298M (or $384M), and EV of -GBP 62.3M (or -$80.3M).

See PureTech Health trading valuation data

PureTech Health Stock Data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
-$80.3M	$384M	XXX	XXX	XXX	XXX	$-0.64

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

PureTech Health Valuation Multiples

As of April 24, 2025, PureTech Health has market cap of $384M and EV of -$80.3M.

PureTech Health's trades at n/a LTM EV/Revenue multiple, and 0.6x LTM EBITDA.

Analysts estimate PureTech Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See valuation multiples for PureTech Health and 10K+ public comps

PureTech Health Financial Valuation Multiples

	FY 2024	FY 2025E	FY 2026E	FY 2027E
EV	-$80.3M	XXX	XXX	XXX
EV/Revenue	n/a	XXX	XXX	XXX
EV/EBITDA	0.6x	XXX	XXX	XXX
P/E	-2.2x	XXX	XXX	XXX
P/E/Growth	n/a	XXX	XXX	XXX
EV/FCF	0.8x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get PureTech Health Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

PureTech Health Valuation Multiples

PureTech Health's NTM/LTM revenue growth is n/a

PureTech Health's revenue per employee for the last fiscal year averaged $11K, while opex per employee averaged $2.1M for the same period.

Over next 12 months, PureTech Health's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .

Analysts estimate PureTech Health's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

See operational valuation multiples for PureTech Health and other 10K+ public comps

PureTech Health Operational Valuation Multiples

	FY 2024	NTM	FY 2025E	FY 2026E	FY 2027E
Revenue Growth	n/a	XXX	XXX	XXX	XXX
EBITDA Margin	n/a	XXX	XXX	XXX	XXX
EBITDA Growth	454%	XXX	XXX	XXX	XXX
Rule of 40 (SaaS-only)	n/a	XXX	XXX	XXX	XXX
Revenue per Employee	$11K	XXX	XXX	XXX	XXX
Opex per Employee	$2.1M	XXX	XXX	XXX	XXX
S&M Expenses to Revenue	n/a	XXX	XXX	XXX	XXX
G&A Expenses to Revenue	3357%	XXX	XXX	XXX	XXX
R&D Expenses to Revenue	9831%	XXX	XXX	XXX	XXX
Opex to Revenue	19593%	XXX	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Streaming Platforms

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Explore Valuation Multiples by Industry